← World Journal of Gastrointestinal Pharmacology and Therapeutics

Papers in World Journal of Gastrointestinal Pharmacology and Therapeutics

Page 2 · newest first

51. Opioid analgesics for sedation-based gastrointestinal endoscopyWorld Journal of Gastrointestinal Pharmacology and Therapeutics · 2025
52. Four-strain probiotic exerts a positive effect on irritable bowel syndrome symptoms occurring in inflammatory bowel diseases in absence of inflammation (TRAIN-IBD trial)World Journal of Gastrointestinal Pharmacology and Therapeutics · 2025
53. Probiotics and prebiotics in the treatment of functional constipation in the elderly individualsWorld Journal of Gastrointestinal Pharmacology and Therapeutics · 2025
54. Comorbidities and systemic steroids drive pneumonia risk in inflammatory bowel disease: Propensity score-matched cohort studyWorld Journal of Gastrointestinal Pharmacology and Therapeutics · 2025
55. Nalbuphine vs sufentanil as effective analgesics for postoperative pain management in gastric cancer resectionWorld Journal of Gastrointestinal Pharmacology and Therapeutics · 2025
56. Rebamipide in gastric mucosal protection and healing: An Asian perspectiveWorld Journal of Gastrointestinal Pharmacology and Therapeutics · 2025
57. Comprehensive review of Clostridium difficile infection: Epidemiology, diagnosis, prevention, and treatmentWorld Journal of Gastrointestinal Pharmacology and Therapeutics · 2025
58. Insight into global burden of gastroesophageal reflux disease: Understanding its reach and impactWorld Journal of Gastrointestinal Pharmacology and Therapeutics · 2025
59. Real-world-evidence, prospective-observational study to evaluate safety and effectiveness of rabeprazole dual-delayed-release capsules in patients with gastroesophageal reflux diseaseWorld Journal of Gastrointestinal Pharmacology and Therapeutics · 2025
60. Protective effects of long term antiplatelet and anticoagulant therapy in hospitalized patients with inflammatory bowel diseaseWorld Journal of Gastrointestinal Pharmacology and Therapeutics · 2024
61. Insights of gut-liver axis in hepatic diseases: Mechanisms, clinical implications, and therapeutic potentialsWorld Journal of Gastrointestinal Pharmacology and Therapeutics · 2024
62. Regression of hepatic fibrosis after pharmacological therapy for nonalcoholic steatohepatitisWorld Journal of Gastrointestinal Pharmacology and Therapeutics · 2024
63. Inflammatory bowel disease in Pakistan: Low prevalence or underdiagnosis?World Journal of Gastrointestinal Pharmacology and Therapeutics · 2024
64. Hindi translation and validation of the English version of the gastrointestinal symptom rating scale questionnaire: An observational studyWorld Journal of Gastrointestinal Pharmacology and Therapeutics · 2024
65. Effect of KiwiBiotic on functional constipation and related symptoms: A prospective, single-center, randomized, comparative, crossover studyWorld Journal of Gastrointestinal Pharmacology and Therapeutics · 2024
66. Drugs used for pain management in gastrointestinal surgery and their implicationsWorld Journal of Gastrointestinal Pharmacology and Therapeutics · 2024
67. Therapeutics involved in managing initial and recurrent Clostridium difficile infection: An updated literature reviewWorld Journal of Gastrointestinal Pharmacology and Therapeutics · 2024
68. Downstaging of advanced hepatocellular carcinoma followed by liver transplantation using immune checkpoint inhibitors: Where do we stand?World Journal of Gastrointestinal Pharmacology and Therapeutics · 2024
69. Biliary complications associated with weight loss, cholelithiasis and choledocholithiasisWorld Journal of Gastrointestinal Pharmacology and Therapeutics · 2024
70. Efficacy and tolerability of chitin-glucan combined with simethicone (GASTRAP® DIRECT) in irritable bowel syndrome: A prospective, open-label, multicenter studyWorld Journal of Gastrointestinal Pharmacology and Therapeutics · 2024
71. Risk factors and outcomes of peptic ulcer bleed in a Pakistani population: A single-center observational studyWorld Journal of Gastrointestinal Pharmacology and Therapeutics · 2024
72. Treatment endpoints in ulcerative colitis: Does one size fit all?World Journal of Gastrointestinal Pharmacology and Therapeutics · 2024
73. Hepatitis C virus treatment with glecaprevir and pibrentasvir in patients co-prescribed carbamazepine: Three case reportsWorld Journal of Gastrointestinal Pharmacology and Therapeutics · 2023
74. Update on the strategy for intravenous fluid treatment in acute pancreatitisWorld Journal of Gastrointestinal Pharmacology and Therapeutics · 2023
75. Cinnamic acid regulates the intestinal microbiome and short-chain fatty acids to treat slow transit constipationWorld Journal of Gastrointestinal Pharmacology and Therapeutics · 2023
76. “Timing of percutaneous endoscopic gastrostomy tube placement in post-stroke patients does not impact mortality, complications, or outcomes”: CommentaryWorld Journal of Gastrointestinal Pharmacology and Therapeutics · 2023
77. Effect of small bowel transit time on accuracy of video capsule endoscopy in evaluating suspected small bowel bleedingWorld Journal of Gastrointestinal Pharmacology and Therapeutics · 2022
78. Timing of percutaneous endoscopic gastrostomy tube placement in post-stroke patients does not impact mortality, complications, or outcomesWorld Journal of Gastrointestinal Pharmacology and Therapeutics · 2022
79. Impact of epinephrine volume on further bleeding due to high-risk peptic ulcer disease in the combination therapy eraWorld Journal of Gastrointestinal Pharmacology and Therapeutics · 2022
80. Biliary atresia and congenital disorders of the extrahepatic bile ductsWorld Journal of Gastrointestinal Pharmacology and Therapeutics · 2022
81. Primary hyperparathyroidism presenting as acute pancreatitis: An institutional experience with review of the literatureWorld Journal of Gastrointestinal Pharmacology and Therapeutics · 2022
82. Overweight and abdominal fat are associated with normal bone mineral density in patients with ulcerative colitisWorld Journal of Gastrointestinal Pharmacology and Therapeutics · 2022
83. Fuzhuan brick tea affects obesity process by modulating gut microbiotaWorld Journal of Gastrointestinal Pharmacology and Therapeutics · 2022
84. Hypereosinophilic syndrome presenting as eosinophilic gastroenteritis disorder and splinter hemorrhages: A case reportWorld Journal of Gastrointestinal Pharmacology and Therapeutics · 2022
85. Melatonin restores zinc levels, activates the Keap1/Nrf2 pathway, and modulates endoplasmic reticular stress and HSP in rats with chronic hepatotoxicityWorld Journal of Gastrointestinal Pharmacology and Therapeutics · 2022
86. Addition of castor oil as a booster in colon capsule regimens significantly improves completion rates and polyp detectionWorld Journal of Gastrointestinal Pharmacology and Therapeutics · 2021
87. Influence of nutritional status in the postoperative period of patients with inflammatory bowel diseaseWorld Journal of Gastrointestinal Pharmacology and Therapeutics · 2021
88. Advances in treatment and prevention of hepatitis BWorld Journal of Gastrointestinal Pharmacology and Therapeutics · 2021
89. Castor oil as booster for colon capsule endoscopy preparation reduction: A prospective pilot study and patient questionnaireWorld Journal of Gastrointestinal Pharmacology and Therapeutics · 2021
90. Overview of drug induced liver injury in Brazil: What is the role of public health policy on the evidence?World Journal of Gastrointestinal Pharmacology and Therapeutics · 2021
91. Clinical features and relative factors of constipation in a cohort of Chinese patients with Parkinson's diseaseWorld Journal of Gastrointestinal Pharmacology and Therapeutics · 2021
92. Increased colon transit time and faecal load in irritable bowel syndromeWorld Journal of Gastrointestinal Pharmacology and Therapeutics · 2021
93. Oral encapsulated transforming growth factor β1 reduces endogenous levels: Effect on inflammatory bowel diseaseWorld Journal of Gastrointestinal Pharmacology and Therapeutics · 2020
94. Do liver metastases from gastric cancer contraindicate aggressive surgical resection? A 14-year single-center experienceWorld Journal of Gastrointestinal Pharmacology and Therapeutics · 2020
95. Bowel adhesion and therapy with the stable gastric pentadecapeptide BPC 157, L-NAME and L-arginine in ratsWorld Journal of Gastrointestinal Pharmacology and Therapeutics · 2020
96. Hospitalizations and in-hospital mortality for inflammatory bowel disease in BrazilWorld Journal of Clinical Cases · 2020
97. Shared changes in angiogenic factors across gastrointestinal vascular conditions: A pilot studyWorld Journal of Gastrointestinal Pharmacology and Therapeutics · 2020
98. Management of gastric outlet obstruction: Focusing on endoscopic approachWorld Journal of Gastrointestinal Pharmacology and Therapeutics · 2020
99. Validation of American Joint Committee on Cancer 8th edition of TNM staging in resected distal pancreatic cancerWorld Journal of Gastrointestinal Pharmacology and Therapeutics · 2020
100. Gastrointestinal symptoms in acromegaly: A case control studyWorld Journal of Gastrointestinal Pharmacology and Therapeutics · 2020